Evidence map›Paper›PMID 41285802›Full record

ArticleNature communications2025

mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset.

Ying Xiong, Aowen Wang, Yu Kang, Chao Shen, Chang-Yu Hsieh, Tingjun Hou

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ying XiongCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0009-0006-3877-2913
Aowen WangCollege of Computer Science and Technology, Zhejiang University, Hangzhou, China.
Yu KangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-0999-8802
Chao ShenCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0003-2783-5529
Chang-Yu HsiehCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. kimhsieh@zju.edu.cn.ORCID http://orcid.org/0000-0002-6242-4218
Tingjun HouCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. tingjunhou@zju.edu.cn.ORCID http://orcid.org/0000-0001-7227-2580

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22373085
6 · The paper itself

Abstract

Designing effective mRNA sequences for therapeutics remains a formidable challenge. Inspired by successes in protein design, language models (LMs) are now being applied to RNA, but progress is often impeded by the lack of comprehensive training data. Existing models are frequently limited to UTR or CDS regions, restricting their application for complete mRNA sequences. We introduce mRNABERT, a robust, all-in-one mRNA designer pre-trained on the largest available mRNA dataset. To enhance performance, we propose a dual tokenization scheme with a cross-modality contrastive learning framework to integrate semantic information from protein sequences. On a comprehensive benchmark, mRNABERT demonstrates state-of-the-art performance, outperforming previous models in the majority of tasks for 5' UTR and CDS design, RNA-binding protein (RBP) site prediction, and full-length mRNA property prediction. It also surpasses large protein models in several related tasks. In conclusion, mRNABERT's superior performance across these diverse tasks signifies a substantial leap forward in mRNA research and therapeutic development.

Indexed as

Computational BiologyRNA, Messenger5' Untranslated RegionsAlgorithmsHumansLanguageRNA-Binding ProteinsSemanticsSoftware5' Untranslated RegionsRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID41285802
PMCPMC12644827

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.